⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XLO News
Xilio Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
XLO
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
XLO
Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting
globenewswire.com
XLO
Form 8-K
sec.gov
XLO
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
globenewswire.com
XLO
Form 8-K
sec.gov
XLO
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
globenewswire.com
XLO
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
XLO
Form 8-K
sec.gov
XLO
Xilio Therapeutics Announces Pricing of Underwritten Offering
globenewswire.com
XLO
GILD